Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Semma Therapeutics received early financing of $44.0M on 2015-03-24.
| Series | Round size | Date |
|---|---|---|
| Series A | $44M | 03/2015 |
| Grant | $5M | 09/2016 |
| Series B | $114M | 11/2017 |
| Investors | Security type |
|---|---|
| MPM Capital | Series A |
| ARCH Venture Partners | Series A |
| F-Prime Capital | Series A |
| MEDTRONIC PLC | Series A |
| Sinopharm Capital | Series B |
| Novartis | Series B |
| Eight Roads Ventures | Series B |
| ORI Capital | Series B |
| JDRF T1D Fund | Series B |
| MPM Capital | Series B |
| ARCH Venture Partners | Series B |
| COWEN INC. | Series B |
| F-Prime Capital | Series B |
| Wu Capital | Series B |
| MEDTRONIC PLC | Series B |
| 6 Dimensions Capital | Series B |
Zippia gives an in-depth look into the details of Semma Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Semma Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Semma Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Semma Therapeutics. The data presented on this page does not represent the view of Semma Therapeutics and its employees or that of Zippia.
Semma Therapeutics may also be known as or be related to SEMMA THERAPEUTICS, INC., Semma Therapeutics, Semma Therapeutics Inc and Semma Therapeutics, Inc.